Semantic Scholar uses AI to extract papers important to this topic.
Since the identification of the novel reassortant avian influenza A (H7N9) virus in China in 2013, until Jun 30, 2017, the virus… Expand DAS181, (study drug, Fludase®) was developed for treatment of influenza and parainfluenza infections. Delivered by inhalation… Expand The article presents the results of studies of the antioxidant and antiradical capacity of red table wines. It is shown that the… Expand Human infections caused by avian influenza A virus type subtype H7N9 have been associated with substantial morbidity and… Expand ABSTRACT Since 2011, outbreaks caused by influenza A(H3N2) variant [A(H3N2)v] viruses have become a public health concern in the… Expand BACKGROUND
influenza viruses (IFVs) frequently achieve resistance to antiviral drugs, necessitating the development of compounds… Expand BACKGROUND
DAS181 (Fludase) is a sialidase fusion protein in clinical development as a broad-spectrum anti-influenza virus (IFV… Expand Antiviral drug resistance for influenza therapies remains a concern due to the high prevalence of H1N1 2009 seasonal influenza… Expand Background The recent emergence of a novel pandemic influenza A(H1N1) strain in humans exemplifies the rapid and unpredictable… Expand Increasing resistance to currently available influenza antivirals highlights the need to develop alternate approaches for the… Expand